About
| About CONTRAST |
|
CONTRAST is a multidisciplinary alliance bringing together key skills and expertise to generate new knowledge on biological, environmental and socio-economic factors relating to schistosomiasis in sub-Saharan Africa. The project will complement ongoing chemotherapy campaigns based on the drug praziquantel and deliver more effective strategies for long-term control of this debilitating disease. The project addresses the basic need of endemic countries to improve understanding of schistosomiasis transmission, in order to target, and make best use of limited resources for control.
Project objectives
It is the overall aim of this project to achieve sustainable schistosomiasis control at the public health level in selected countries in sub-Saharan Africa through development of locally-adapted and appropriate intervention strategies, complementary with ongoing morbidity control using the anthelmintic drug praziquantel (PZQ). Partners
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Id |
Partner |
Country |
| 1 | DBL - Institute for Health Research and Development | Denmark |
| 2 | Natural History Museum | UK |
| 3 | Swiss Tropical Institute | Switzerland |
| 4 | Imperial College London | UK |
| 5 | Makerere University | Uganda |
| 6 | University of Zambia |
Zambia |
| 7 | National Museums of Kenya | Kenya |
| 8 | Institut Senegalais de Recherches Agricoles | Senegal |
| 9 | Programme National de la lutte contre la Bilharziose et Geohelminths |
Niger |
| 10 | Centre for Schistosomiasis and Parasitology | Cameroon |
| 11 | Ministry of Health- Helminth Control Laboratory | Zanzibar |
| 12 | National Institute of Medical Research | Tanzania |
| 13 | Coris Bioconcept |
Belgium |
| 14 | Ministry of Health-Vector Control Division | Uganda |














